Tissue-of-origin-specific gene repositioning in breast and prostate cancer

被引:22
|
作者
Meaburn, Karen J. [1 ]
Agunloye, Olufunmilayo [1 ]
Devine, Michelle [1 ]
Leshner, Marc [1 ]
Roloff, Gregory W. [1 ]
True, Lawrence D. [2 ]
Misteli, Tom [1 ]
机构
[1] NCI, NIH, Bethesda, MD 20892 USA
[2] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
Nuclear architecture; Spatial gene positioning; Breast cancer; Prostate cancer; Tissue specificity; ORDER CHROMATIN ARRANGEMENTS; NUCLEAR LAMINA INTERACTIONS; INTERPHASE NUCLEI; HUMAN-CHROMOSOMES; CELL-NUCLEI; SPATIAL-ORGANIZATION; GENOME ORGANIZATION; INACTIVE GENES; TERRITORIES; DIFFERENTIATION;
D O I
10.1007/s00418-015-1401-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Genes have preferential non-random spatial positions within the cell nucleus. The nuclear position of a subset of genes differ between cell types and some genes undergo repositioning events in disease, including cancer. It is currently unclear whether the propensity of a gene to reposition reflects an intrinsic property of the locus or the tissue. Using quantitative FISH analysis of a set of genes which reposition in cancer, we test here the tissue specificity of gene repositioning in normal and malignant breast or prostate tissues. We find tissue-specific organization of the genome in normal breast and prostate with 40 % of genes occupying differential positions between the two tissue types. While we demonstrate limited overlap between gene sets that repositioned in breast and prostate cancer, we identify two genes that undergo disease-related gene repositioning in both cancer types. Our findings indicate that gene repositioning in cancer is tissue-of-origin specific.
引用
收藏
页码:433 / 446
页数:14
相关论文
共 50 条
  • [21] Regulation of the prostate specific antigen gene in breast cancer cell lines by steroid hormones.
    Zarghami, N
    Grass, L
    Diamandis, EP
    CLINICAL CHEMISTRY, 1996, 42 (06) : 586 - 586
  • [22] The significance of prostate specific antigen (PSA) in breast cancer
    Klijn, JGM
    Diamandis, EP
    Yu, H
    Look, MP
    Gelder, MEMV
    van Putten, WLJ
    Foekens, JA
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S106 - S107
  • [23] Immunohistochemical analysis of prostate specific antigen in breast cancer
    Miller, MK
    Unger, PD
    Bleiweiss, IJ
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 68 (02) : 111 - 116
  • [24] Immunohistochemical analysis of prostate specific antigen in breast cancer*
    Michael K. Miller
    Pamela D. Unger
    Ira J. Bleiweiss
    Breast Cancer Research and Treatment, 2001, 68 : 111 - 116
  • [25] Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer
    Sauter, ER
    Tichansky, DS
    Cheroneva, I
    Diamandis, EP
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2002, 110 (03) : 241 - 246
  • [26] Expression of prostate specific antigen in male breast cancer
    Carder, PJ
    Speirs, V
    Ramsdale, J
    Lansdown, MRJ
    JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (01) : 69 - 71
  • [27] Prostate specific antigen (PSA) in breast and ovarian cancer
    Kucera, E
    Kainz, C
    Tempfer, C
    Zeillinger, R
    Koelbl, H
    Sliutz, G
    ANTICANCER RESEARCH, 1997, 17 (6D) : 4735 - 4737
  • [28] Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors
    Uma R Chandran
    Rajiv Dhir
    Changqing Ma
    George Michalopoulos
    Michael Becich
    John Gilbertson
    BMC Cancer, 5
  • [29] Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors
    Chandran, UR
    Dhir, R
    Ma, CQ
    Michalopoulos, G
    Becich, M
    Gilbertson, J
    BMC CANCER, 2005, 5 (1)
  • [30] Comparison of human prostate specific glandular kallikrein 2 and prostate specific antigen gene expression in prostate with gene amplification and overexpression of prostate specific glandular kallikrein 2 in tumor tissue
    Herrala, AM
    Porvari, KS
    Kyllönen, AP
    Vihko, PT
    CANCER, 2001, 92 (12) : 2975 - 2984